Streetbeat News

ONTTF

Oxford Nanopore Technologies Plc

Industry

Testing Laboratories

Open

1.64

Mkt cap

1.6B

Volume

208

High

1.68

P/E Ratio

-6.72

52-wk high

2.34

Low

1.64

Div yield

N/A

52-wk low

1.10

Oxford Nanopore Technologies has partnered with UK Biobank to create the world's first large-scale epigenetic dataset. This project will use Oxford Nanopore's sequencing technology to map the epigenome of 50,000 samples, aiming to provide insights into disease mechanisms such as cancer and dementia.

Portfolio Pulse from

November 27, 2024 | 12:45 am

Oxford Nanopore has announced a strategic partnership with the UK Government to advance genomics-driven healthcare innovation. This collaboration involves Genomics England, UK Biobank, and NHS England, aiming to enhance genomics-based research and healthcare in the UK.

Portfolio Pulse from

November 05, 2024 | 12:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.